By Katherine Hamilton

Shuttle Pharmaceuticals named Yuying Liang as its next chief financial officer.

Liang will succeed Chris Cooper, who will continue to serve as interim chief executive, the cancer treatment company said Monday.

Liang, 35, has been working with the company via her company Yuying Liang Professional, where she has been performing bookkeeping, accounting and financial reporting.

Liang is a certified public accountant who has worked with public and private companies across multiple sectors. Most recently, she was named chief financial officer of iSpecimen in December 2024.

Liang also currently serves as chief financial officer of BlockchainK2, Goldhills Holding, Intact Gold, Kincora Copper, Transatlantic Mining and Ultra Brands. She is chief financial officer and director at Modern Plant Based Foods and Montego Resources.

Shuttle plans to pay Liang a monthly fee of $15,000 plus taxes, it said.

Separately, Sachin Pathigoda resigned from his position on the company's board of directors. The board has started looking for potential candidates to fill the vacancy.

Write to Katherine Hamilton at katherine.hamilton@wsj.com

(END) Dow Jones Newswires

January 12, 2026 16:47 ET (21:47 GMT)

Copyright (c) 2026 Dow Jones & Company, Inc.